PMID- 34015592 OWN - NLM STAT- MEDLINE DCOM- 20210617 LR - 20210617 IS - 1873-264X (Electronic) IS - 0731-7085 (Linking) VI - 202 DP - 2021 Aug 5 TI - A validated UHPLC-MS/MS method for pharmacokinetic and brain distribution studies of twenty constituents in rat after oral administration of Jia-Wei-Qi-Fu-Yin. PG - 114140 LID - S0731-7085(21)00251-X [pii] LID - 10.1016/j.jpba.2021.114140 [doi] AB - A rapid ultra-high performance liquid chromatography coupled with triple quadrupole tandem mass spectrometry (UHPLC-QqQ MS/MS) approach with high sensitivity and selectivity was developed for the quantification of twenty compounds, including 9 saponins, 8 flavonoids, 2 oligosaccharide esters and 1 phenolic acid, in rat plasma and brain, which was administrated intragastrically with Jia-Wei-Qi-Fu-Yin (JWQFY), Mass spectrometric detection was operated under multiple reaction monitoring (MRM) mode. All calibration curves possessed good linearity with correlation coefficients ( r(2)) higher than 0.9916 in their respective linear ranges. For intra- and inter-day precision, all the relative standard deviations (RSDs) at different levels were less than 14.68 %. Based on the UHPLC-QqQ MS/MS quantitative results, pharmacokinetic study and brain distribution of multiple components in JWQFY was then successfully performed. As a result, constituents with discrepancy structures showed diverse pharmacokinetic and distribution characteristics. For instance, ferulic acid (phenolic acid), 3, 6'-disinapoyl sucrose and tenuifoliside A (oligosaccharide esters) showed short T(max) (< 10 min), whereas the T(max) of ginsenosides Rb(1), Rb(2) and Rc (ppd-type terpenoid saponins) were much longer (> 4 h). Besides, ferulic acid, epimedin C, icariin, glycyrrhizin, ginsenoside Rb(1) and ginsenoside Rg(1) were considered as the potential effective ingredients of JWQFY because of their relatively high exposure to blood and brain. Our study would provide relevant information for discovery of pharmacodynamic ingredients, as well as further action mechanisms investigations of JWQFY. CI - Copyright (c) 2021. Published by Elsevier B.V. FAU - An, Hai-Ming AU - An HM AD - State Key Laboratory of Natural Medicines, School of Traditional Chinese Pharmacy, China Pharmaceutical University, No. 24 Tongjia Lane, Nanjing, 210009, China. FAU - Li, Meng-Ning AU - Li MN AD - State Key Laboratory of Natural Medicines, School of Traditional Chinese Pharmacy, China Pharmaceutical University, No. 24 Tongjia Lane, Nanjing, 210009, China. FAU - Yang, Hua AU - Yang H AD - State Key Laboratory of Natural Medicines, School of Traditional Chinese Pharmacy, China Pharmaceutical University, No. 24 Tongjia Lane, Nanjing, 210009, China. FAU - Pang, Han-Qing AU - Pang HQ AD - State Key Laboratory of Natural Medicines, School of Traditional Chinese Pharmacy, China Pharmaceutical University, No. 24 Tongjia Lane, Nanjing, 210009, China. FAU - Qu, Cheng AU - Qu C AD - State Key Laboratory of Natural Medicines, School of Traditional Chinese Pharmacy, China Pharmaceutical University, No. 24 Tongjia Lane, Nanjing, 210009, China. FAU - Xu, Yi AU - Xu Y AD - Beijing Zhongyan Tongrentang Pharmaceutical R&D co., Ltd, Beijing, 100079, China. FAU - Liu, Run-Zhou AU - Liu RZ AD - State Key Laboratory of Natural Medicines, School of Traditional Chinese Pharmacy, China Pharmaceutical University, No. 24 Tongjia Lane, Nanjing, 210009, China. FAU - Peng, Chao AU - Peng C AD - State Key Laboratory of Natural Medicines, School of Traditional Chinese Pharmacy, China Pharmaceutical University, No. 24 Tongjia Lane, Nanjing, 210009, China. FAU - Li, Ping AU - Li P AD - State Key Laboratory of Natural Medicines, School of Traditional Chinese Pharmacy, China Pharmaceutical University, No. 24 Tongjia Lane, Nanjing, 210009, China. Electronic address: liping2004@126.com. FAU - Gao, Wen AU - Gao W AD - State Key Laboratory of Natural Medicines, School of Traditional Chinese Pharmacy, China Pharmaceutical University, No. 24 Tongjia Lane, Nanjing, 210009, China. Electronic address: gw_cpu@126.com. LA - eng PT - Journal Article DEP - 20210513 PL - England TA - J Pharm Biomed Anal JT - Journal of pharmaceutical and biomedical analysis JID - 8309336 RN - 0 (Drugs, Chinese Herbal) RN - 0 (qi-fu-yin) SB - IM MH - Administration, Oral MH - Animals MH - Brain MH - Chromatography, High Pressure Liquid MH - *Drugs, Chinese Herbal MH - Rats MH - Reproducibility of Results MH - *Tandem Mass Spectrometry OTO - NOTNLM OT - Brain distribution OT - Jia-Wei-Qi-Fu-Yin OT - Multiple constituents OT - Pharmacokinetics OT - UHPLC-MS/MS COIS- Declaration of Competing Interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper. EDAT- 2021/05/21 06:00 MHDA- 2021/06/22 06:00 CRDT- 2021/05/20 20:18 PHST- 2020/12/17 00:00 [received] PHST- 2021/04/09 00:00 [revised] PHST- 2021/05/10 00:00 [accepted] PHST- 2021/05/21 06:00 [pubmed] PHST- 2021/06/22 06:00 [medline] PHST- 2021/05/20 20:18 [entrez] AID - S0731-7085(21)00251-X [pii] AID - 10.1016/j.jpba.2021.114140 [doi] PST - ppublish SO - J Pharm Biomed Anal. 2021 Aug 5;202:114140. doi: 10.1016/j.jpba.2021.114140. Epub 2021 May 13.